Robert Zahler

Discovery of Dapagliflozin: A Potent, Selective Renal Sodium-Dependent Glucose Cotransporter 2 (SGLT2) Inhibitor for the Treatment of Type 2 Diabetes

Wei Meng, Bruce A. Ellsworth, Alexandra A. Nirschl et al. · Journal of Medicinal Chemistry · 2008 · 612 citations · Full text

Metabolic Syndrome, Diabetes Management, Biochemistry +10

Identification of BMS-200475 as a potent and selective inhibitor of hepatitis B virus

Steven Innaimo, Maria Seifer, Gregory S. Bisacchi et al. · Antimicrobial Agents and Chemotherapy · 1997 · 273 citations · Full text

Hbv Replication, Viral Hepatitis, Mitochondrial Dna Content +14

Total synthesis of the polyether antibiotic ionomycin

David A. Evans, Robert L. Dow, Thomas L. Shih et al. · Journal of the American Chemical Society · 1990 · 235 citations

Bioorganic Chemistry, Antibiotic Adjuvant, Altmetric Attention Score +18

BMS-200475, a novel carbocyclic 2′-deoxyguanosine analog with potent and selective anti-hepatitis B virus activity in vitro

Gregory S. Bisacchi, Sam Chao, C. Bachard et al. · Bioorganic & Medicinal Chemistry Letters · 1997 · 141 citations

Viral Hepatitis, Drug Discovery, Medicine +8

Bisubstrate inhibitors of farnesyltransferase: a novel class of specific inhibitors of ras transformed cells.

Veeraswamy Manne, Ning Yan, Carboni Jm et al. · PubMed · 1995 · 132 citations